David J. Malwitz

634 total citations
6 papers, 539 citations indexed

About

David J. Malwitz is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, David J. Malwitz has authored 6 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Organic Chemistry and 1 paper in Pharmacology. Recurrent topics in David J. Malwitz's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Synthesis and biological activity (2 papers) and Fungal Plant Pathogen Control (1 paper). David J. Malwitz is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Synthesis and biological activity (2 papers) and Fungal Plant Pathogen Control (1 paper). David J. Malwitz collaborates with scholars based in United States and Germany. David J. Malwitz's co-authors include Kevin J. Curran, Lourdes Toral‐Barza, Arie Zask, Jeroen C. Verheijen, Paweł Nowak, Ker Yu, Semiramis Ayral‐Kaloustian, Tarek S. Mansour, James J. Gibbons and Judy Lucas and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and ACS Medicinal Chemistry Letters.

In The Last Decade

David J. Malwitz

6 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Malwitz United States	5	428	128	74	60	56	6	539
Robert H. Sinnamon United States	6	510 1.2×	35 0.3×	47 0.6×	38 0.6×	30 0.5×	7	566
Martina Fitzek United Kingdom	8	213 0.5×	91 0.7×	33 0.4×	9 0.1×	38 0.7×	21	369
Steve W. Elmore United States	3	369 0.9×	32 0.3×	27 0.4×	40 0.7×	46 0.8×	4	437
Juran Kato‐Stankiewicz United States	7	347 0.8×	40 0.3×	54 0.7×	28 0.5×	22 0.4×	9	484
Chu Myong Seong South Korea	12	360 0.8×	32 0.3×	38 0.5×	20 0.3×	36 0.6×	30	511
Brian Zifcak United States	7	431 1.0×	125 1.0×	17 0.2×	31 0.5×	43 0.8×	10	570
Ju In Eom South Korea	8	362 0.8×	26 0.2×	29 0.4×	32 0.5×	43 0.8×	10	475
Michael Grondine United States	8	421 1.0×	39 0.3×	76 1.0×	50 0.8×	36 0.6×	14	544
Akito Nakamura Japan	8	326 0.8×	45 0.4×	58 0.8×	63 1.1×	42 0.8×	13	424
Hai-Xiao Zhai	5	582 1.4×	162 1.3×	18 0.2×	38 0.6×	39 0.7×	6	717

Countries citing papers authored by David J. Malwitz

Since Specialization

Citations

This map shows the geographic impact of David J. Malwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Malwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Malwitz more than expected).

Fields of papers citing papers by David J. Malwitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Malwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Malwitz. The network helps show where David J. Malwitz may publish in the future.

Co-authorship network of co-authors of David J. Malwitz

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Malwitz. A scholar is included among the top collaborators of David J. Malwitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Malwitz. David J. Malwitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Harrington, Paul E., Kaustav Biswas, David J. Malwitz, et al.. (2014). Unfolded Protein Response in Cancer: IRE1α Inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell Viability. ACS Medicinal Chemistry Letters. 6(1). 68–72. 74 indexed citations

2.

Yu, Ker, Lourdes Toral‐Barza, Celine Shi, et al.. (2009). Biochemical, Cellular, and In vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin. Cancer Research. 69(15). 6232–6240. 277 indexed citations

3.

Nowak, Paweł, Derek C. Cole, Natasja Brooijmans, et al.. (2009). Discovery of Potent and Selective Inhibitors of the Mammalian Target of Rapamycin (mTOR) Kinase. Journal of Medicinal Chemistry. 52(22). 7081–7089. 46 indexed citations

4.

Verheijen, Jeroen C., David J. Richard, Kevin J. Curran, et al.. (2009). Discovery of 4-Morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as Highly Potent and Selective ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 6-Aryl Substituent. Journal of Medicinal Chemistry. 52(24). 8010–8024. 48 indexed citations

5.

Zask, Arie, Jeroen C. Verheijen, Kevin J. Curran, et al.. (2009). ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin: Design and Synthesis of Highly Potent and Selective Pyrazolopyrimidines. Journal of Medicinal Chemistry. 52(16). 5013–5016. 93 indexed citations

6.

Grossie, David A., David J. Malwitz, & Daniel M. Ketcha. (2006). N,N-Dimethyl-1-phenylsulfonyl-1H-pyrrole-3-sulfonamide. Acta Crystallographica Section E Structure Reports Online. 62(3). o980–o982. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact